Avita Medical's ReCell(R) devices now treating burns in South Africa and Benelux - Seite 2
"South Africa and the Benelux countries, whilst different in their prospects, both represent particular opportunities to bring the benefits of our ReCell® devices to patients," said Avita Medical's CEO, Adam Kelliher. "We are confident that we have found the right partners in these territories, and that they will be able to explain to medical professionals the verities of our breakthrough approach to wound healing."
Avita Medical provides clinical support to its distributors sales teams, to help in their interactions with medical professionals. Over the past year, Avita has escalated its commercialization activities with new distributors appointed in the UK, Germany, France, China, Japan, South Korea, Malaysia and Iran.
ABOUT AVITA MEDICAL LIMITED
Avita Medical develops and distributes regenerative products for the treatment of a broad range of wounds, scars and skin defects. Avita's patented and proprietary collection and application technology provides innovative treatment solutions derived from a patient's own skin. The Company's regenerative product portfolio includes ReCell® for burns & plastic reconstructive procedures, ReGenerCell® for chronic wounds and ReNovaCell® of restoration of pigmentation and cosmesis. ReCell®, ReGenerCell® and ReNovaCell® are patented, CE‐marked for Europe. ReCell® is TGA‐registered in Australia, and CFDA‐cleared in China. In the United States, ReCell® is an investigational device limited by federal law to investigational use, and a pivotal U.S. approval trial is underway.
To learn more, visit www.avitamedical.com.
AVITA'S REGENERATIVE TECHNOLOGY AND RES™
Avita Medical's unique proprietary technology enables a clinician to rapidly create, at the point of care in approximately 30 minutes, Regenerative Epithelial Suspension (RES™) using a small sample of the patient's skin. RES™ is an autologous suspension comprising the cells and wound healing factors necessary to regenerate natural, healthy skin. RES™ has a broad range of applications and can be used to restart healing in unresponsive wounds, to repair burns using less donor skin yet with improved functional and aesthetic outcomes, and to restore pigmentation and improve cosmesis of damaged skin.
Lesen Sie auch
Avita Medical Ltd
Adam Kelliher
Chief Executive Officer
Phone: +44 (0) 1763 269 772
akelliher@avitamedical.com
Avita Medical Ltd
Tim Rooney
Chief Financial Officer
Phone: + 1 (818) 356-9400
trooney@avitamedical.com
Avita Medical Ltd
Gabriel Chiappini
Company Secretary
Phone +61(0) 8 9474 7738
gabriel@laurus.net.au
UK/EU
Instinctif Partners
Gemma Howe/Sue Charles
Phone +44 (0)20 7866 7860
avitamedical@instinctif.com
Australia
Monsoon Communications
Dean Felton
Investor Relations / PR
Phone: +61 3 9620 3333
Mobile: +61 (0) 411 698 499
deanf@monsoon.com.au